S&P 500   2,991.48 (-0.14%)
DOW   27,014.49 (-0.04%)
QQQ   192.98 (-0.28%)
AAPL   234.58 (-0.31%)
FB   186.92 (-1.04%)
MSFT   139.84 (-1.22%)
GOOGL   1,248.53 (+0.51%)
AMZN   1,778.77 (+0.64%)
CGC   19.65 (-2.24%)
NVDA   197.60 (+0.62%)
MU   46.39 (-0.13%)
BABA   174.97 (-0.18%)
GE   8.98 (+0.90%)
TSLA   260.29 (+0.93%)
AMD   30.96 (+0.78%)
T   37.98 (+0.21%)
F   9.16 (+0.99%)
ACB   3.65 (-2.92%)
PRI   125.06 (+1.12%)
NFLX   284.16 (-0.03%)
BAC   30.55 (+2.76%)
GILD   65.63 (+0.51%)
DIS   130.12 (+0.28%)
S&P 500   2,991.48 (-0.14%)
DOW   27,014.49 (-0.04%)
QQQ   192.98 (-0.28%)
AAPL   234.58 (-0.31%)
FB   186.92 (-1.04%)
MSFT   139.84 (-1.22%)
GOOGL   1,248.53 (+0.51%)
AMZN   1,778.77 (+0.64%)
CGC   19.65 (-2.24%)
NVDA   197.60 (+0.62%)
MU   46.39 (-0.13%)
BABA   174.97 (-0.18%)
GE   8.98 (+0.90%)
TSLA   260.29 (+0.93%)
AMD   30.96 (+0.78%)
T   37.98 (+0.21%)
F   9.16 (+0.99%)
ACB   3.65 (-2.92%)
PRI   125.06 (+1.12%)
NFLX   284.16 (-0.03%)
BAC   30.55 (+2.76%)
GILD   65.63 (+0.51%)
DIS   130.12 (+0.28%)
Log in

ProtoKinetix Stock Price, News & Analysis (OTCMKTS:PKTX)

$0.10
0.00 (0.00 %)
(As of 10/16/2019 10:01 AM ET)
Today's Range
$0.10
Now: $0.10
$0.10
50-Day Range
$0.09
MA: $0.13
$0.20
52-Week Range
$0.05
Now: $0.10
$0.32
Volume15,843 shs
Average Volume150,387 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
ProtoKinetix, Incorporated, a research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins (AFGPs) or anti-aging glycoproteins (AAGPs). The company's AFGPs have commercial applications primarily in food and crop preservation at freezing temperatures. Its AAGPs have commercial applications in the harvesting, storage, and transplantation of cells, tissues, and organs; and treatments for conditions and diseases caused by stress factors, including UV radiation, oxidation, and inflammation. It has collaboration agreement with Proactive Immune Sciences Corporation to test AAGP in immune cell cryopreservation recovery; and a research agreement with the University of British Columbia to test neuronal retinal cells in living tissue for the treatment of macular degeneration. The company was formerly known as RJV Network, Inc. and changed its name to ProtoKinetix, Incorporated in July 2003. ProtoKinetix, Incorporated was founded in 1999 and is based in Marietta, Ohio.

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:PKTX
Previous SymbolNASDAQ:PKTX
CUSIPN/A
Phone+1-304-2995070

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive PKTX News and Ratings via Email

Sign-up to receive the latest news and ratings for PKTX and its competitors with MarketBeat's FREE daily newsletter.


ProtoKinetix (OTCMKTS:PKTX) Frequently Asked Questions

What is ProtoKinetix's stock symbol?

ProtoKinetix trades on the OTCMKTS under the ticker symbol "PKTX."

Has ProtoKinetix been receiving favorable news coverage?

Media headlines about PKTX stock have been trending very negative on Wednesday, according to InfoTrie. InfoTrie rates the sentiment of news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. ProtoKinetix earned a media sentiment score of -3.3 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 8.0 out of 10, meaning that recent news coverage is very likely to have an effect on the company's share price in the immediate future. View News Stories for ProtoKinetix.

Who are some of ProtoKinetix's key competitors?

What other stocks do shareholders of ProtoKinetix own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ProtoKinetix investors own include Rockwell Medical (RMTI), Rexahn Pharmaceuticals (REXN), Achillion Pharmaceuticals (ACHN), Broadcom (AVGO), Catalyst Biosciences (CBIO), Celsion (CLSN), Cree (CREE), SVB Financial Group (SIVB), Tilray (TLRY) and Aphria (APHA).

Who are ProtoKinetix's key executives?

ProtoKinetix's management team includes the folowing people:
  • Mr. Clarence Edward Smith, Chairman, CEO & Pres (Age 55)
  • Mr. Michael Richard Guzzetta CPA, Chief Financial Officer (Age 61)
  • Dr. Jean-Charles Quirion Ph.D., Head of Researchers for Rouen

How do I buy shares of ProtoKinetix?

Shares of PKTX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is ProtoKinetix's stock price today?

One share of PKTX stock can currently be purchased for approximately $0.10.

What is ProtoKinetix's official website?

The official website for ProtoKinetix is http://www.protokinetix.com/.

How can I contact ProtoKinetix?

ProtoKinetix's mailing address is 412 Mulberry St, MARIETTA, OH 45750-2016, United States. The company can be reached via phone at +1-304-2995070.


MarketBeat Community Rating for ProtoKinetix (OTCMKTS PKTX)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  58 (Vote Outperform)
Underperform Votes:  51 (Vote Underperform)
Total Votes:  109
MarketBeat's community ratings are surveys of what our community members think about ProtoKinetix and other stocks. Vote "Outperform" if you believe PKTX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PKTX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/16/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel